Sam Chun Dang Pharm
CompanySouth KoreaFounded 1943
Sam Chun Dang Pharm develops one asset, in phase 1 (oral insulin in type 1 diabetes). Mostly protein or enzyme acting on Insulin/IGF-1 signalling, glycolysis and INSR; based in South Korea, founded in 1943.
- 1
- Asset
- Furthest stage
- Phase 1
- 1
- Trial
- 0
- Signals
Pipeline
1Activates insulin receptors to regulate glucose uptake and metabolism
Phase 1, Protein or enzyme, Insulin/IGF-1 signalling, Glycolysis, type 1 diabetes
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms4
- Trials1
- Signals1
- Similar companies6